From Concept to Medicine - A Comprehensive Drug Development Journey

Jim Mitchell
  • 4.2 (5)
  • CHEMISTRY
  • SERIES

Welcome to a Complete Drug Development Journey! Have you ever wondered how groundbreaking medicines go from a scientist’s vision to life-saving treatments in hospitals and pharmacies worldwide? The journey of drug development is an intricate, high-stakes adventure—filled with scientific breakthroughs, regulatory twists, and the relentless pursuit of innovation. In this podcast, we take you behind the scenes of pharmaceutical research and development, unraveling the complex and fascinating process that transforms a promising compound into a fully approved, market-ready medicine. Each episode is a deep dive into the critical stages of drug development, including: 🔬 Drug Discovery: Where innovation begins—exploring cutting-edge research, target identification, and the quest for the next medical breakthrough. 🧪 Preclinical Testing: Investigating safety, efficacy, and mechanisms of action before a drug ever reaches human trials. 👩‍⚕️ Clinical Trials: The rigorous, high-stakes world of human testing—what works, what fails, and what it takes to get to the finish line. 📜 Regulatory Approval: Understanding the intricate web of global regulatory agencies, FDA submissions, and the make-or-break moments for new drugs. 🏭 Manufacturing & Scale-Up: From lab to large-scale production—how pharmaceutical companies tackle formulation, stability, and distribution challenges. 💰 Market Access & Commercialization: The economics of drug development—pricing, market dynamics, and the delicate balance between innovation and accessibility. Whether you're a scientist, industry professional, investor, or simply fascinated by the inner workings of the pharmaceutical world, this podcast brings you expert insights, real-world case studies, and in-depth discussions on the past, present, and future of drug development. Join us as we demystify the science, strategy, and business behind the medicines that change lives. Subscribe now and be part of the journey! Access the Notion Template for cGXP Training Modules here: https://www.notion.so/marketplace/templates/cgxp-guidance-and-training-module ***Information in this podcast series is for education only and not meant to construe medical advice. For that, please consult your health care professional.***

See All
  1. 181 - Episode 1 - Introduction to Medical Devices and Their Regulatory Landscape (S25E1)

    EPISODE 1

    181 - Episode 1 - Introduction to Medical Devices and Their Regulatory Landscape (S25E1)

    In this foundational episode, we explore how medical devices are defined and classified by the FDA—a critical first step in navigating the regulatory landscape. Starting with the legal distinction between devices and drugs, we unpack the FDA’s risk-based classification system that categorizes devices into Class I, II, or III based on their potential harm to patients. The discussion delves into how classification affects everything from pre-market submission pathways (like 510(k), De Novo, and PMA) to clinical testing, timelines, and budget planning. Through real-world examples—ranging from dental x-ray holders to implantable prostheses—the episode illustrates the diversity within each risk class and the strategic implications of classification decisions. Listeners also receive a detailed tour through the regulatory ecosystem that supports device safety and effectiveness across a product’s lifecycle. This includes deep dives into Quality System Regulations (21 CFR Part 820), investigational device exemptions (21 CFR Part 812), and risk management standards like ISO 14971 and ISO 14155. The conversation also explores the nuances of U.S. and EU regulatory models, contrasting FDA’s centralized review with Europe’s decentralized notified body system under MDR 2017/745. With thoughtful analogies and accessible language, the episode demystifies regulatory jargon and frames device compliance as a dynamic partnership between innovation and patient safety. This is a must-listen primer for anyone transitioning from pharma to the medical device world.

    33 min
  2. 182 - Episode 2 - The Medical Device Development Lifecycle: From Concept to Commercialization (S25E2)

    EPISODE 2

    182 - Episode 2 - The Medical Device Development Lifecycle: From Concept to Commercialization (S25E2)

    In this comprehensive deep dive, we journey through the entire lifecycle of a medical device—from that first spark of an idea to post-market surveillance. The episode unpacks the structured and often invisible process that transforms innovation into real-world solutions. Starting with conceptualization and design input, the hosts guide listeners through risk management, design controls, verification and validation, and non-clinical testing under GLP. They break down complex concepts like the DHF, DMR, and DHR with relatable analogies, while spotlighting the importance of documentation, traceability, and Quality by Design (QbD). Listeners gain an accessible yet detailed walkthrough of how early decisions shape safety, regulatory strategy, and clinical readiness. But the device's journey doesn’t end at approval. This episode illuminates manufacturing controls, training, process validation, complaint handling, and post-market surveillance with impressive clarity. Real-world examples and regulatory references—including 21 CFR Parts 820, 801, 58, and 812, as well as ISO 13485 and GLP—are woven into the narrative seamlessly. Listeners also learn how recalls, MDR, and FDA audits function to uphold patient safety long after a product hits the market. A thoughtful final discussion on the future of connected, AI-enabled devices underscores the urgency of modernizing regulatory models while preserving rigor. Whether you're new to medical devices or a seasoned pharma veteran, this episode offers a holistic and compelling roadmap to how safe, effective, high-quality devices come to life.

    25 min
  3. 183 - Episode 3 - Device Classification and Premarket Pathways - Navigating FDA Clearance (S25E3)

    EPISODE 3

    183 - Episode 3 - Device Classification and Premarket Pathways - Navigating FDA Clearance (S25E3)

    This episode explores the FDA’s regulatory pathways for medical device clearance and approval, peeling back the layers of risk-based classification and submission strategies. From simple class I devices like elastic bandages to high-stakes class III implants, the discussion walks listeners through how the FDA applies escalating levels of scrutiny depending on patient risk. The episode introduces essential regulatory frameworks including 21 CFR Parts 820, 801, 803, 812, and 814, and explains how manufacturers determine whether their device follows the 510(k), PMA, or De Novo pathway. Real-world examples help ground these regulatory constructs, making complex terms like “substantial equivalence,” “predicate device,” and “investigational device exemption” accessible to listeners. In addition to U.S. pathways, the episode touches on global regulatory harmonization efforts and how international frameworks like the EU MDR compare to the FDA’s system. Listeners also learn how documentation like the Design History File (DHF), Device Master Record (DMR), and Device History Record (DHR) form the regulatory backbone throughout the device lifecycle. With a conversational tone and clear structure, the episode demystifies the steps required to bring a medical device to market while stressing the importance of quality management systems and post-market vigilance. Closing with reflections on how innovation—including AI, connected devices, and personalized tech—will challenge existing regulatory models, the episode invites listeners to consider how the system must adapt while preserving patient safety. It’s a strong primer for professionals crossing over from pharma to devices.

    15 min
  4. 184 - Episode 4 - Quality System Regulation (QSR): The Backbone of Medical Device Manufacturing (21 CFR Part 820) (S25E4)

    EPISODE 4

    184 - Episode 4 - Quality System Regulation (QSR): The Backbone of Medical Device Manufacturing (21 CFR Part 820) (S25E4)

    In this deep dive, we explore the foundation of U.S. medical device quality regulation: the FDA’s Quality System Regulation, also known as 21 CFR Part 820. Framed as more than just paperwork, the QSR is revealed to be the operational heartbeat of device manufacturing, akin to a Michelin-starred kitchen where quality, safety, and consistency are designed into every step. From the first design sketch to the moment a device is packaged, stored, installed, and even serviced, the episode unpacks how manufacturers must embed robust controls across the entire lifecycle. It introduces essential documents like the DHF, DMR, and DHR, and connects them to practical examples in labeling, process validation, and cleaning procedures. The episode also demystifies change control, equipment qualification (DQ/IQ/OQ/PQ), supplier management, and post-market feedback systems. But QSR is more than a technical checklist—it’s a culture. Listeners gain insight into how leadership, proactive risk management (ISO 14971), and a dynamic Quality Management System (QMS) underpin everything from training to audits. The episode also explores the global context, showing how ISO 13485 and EU MDR echo many of the same principles, helping harmonize standards across borders. The discussion on data integrity, ALCOA+ principles, and 21 CFR Part 11 brings modern digital systems into focus. Through compelling analogies and narrative structure, this episode elevates QSR from compliance burden to a living system of trust and safety that protects patients and elevates industry standards. It’s a must-listen for anyone working in—or entering—the medical device space.

    18 min
  5. 185 - Episode 5 - Good Documentation Practices (GDP) in Medical Devices - The ALCOA+ Standard (S25E5)

    EPISODE 5

    185 - Episode 5 - Good Documentation Practices (GDP) in Medical Devices - The ALCOA+ Standard (S25E5)

    In this compelling Deep Dive, we explore the unglamorous but absolutely essential world of medical device documentation. From design inception to post-market surveillance, documentation isn't just red tape—it's the backbone of compliance, traceability, and patient safety. This episode introduces listeners to the U.S. FDA's regulatory foundation in 21 CFR Part 820 and shines a spotlight on ALCOA+ principles: the industry gold standard for ensuring that every action, every test, and every result is accurate, trustworthy, and audit-ready. Through clear examples and engaging conversation, the episode maps how documentation supports every phase of a device's life, from design through manufacturing to corrective actions and recalls. Listeners are guided through the three cornerstone documents of medical device quality—Design History File (DHF), Device Master Record (DMR), and Device History Record (DHR)—with an emphasis on how each connects design intent to execution and oversight. The narrative expands to include digital documentation, introducing 21 CFR Part 11 requirements for electronic records and audit trails. With real-world stakes, like product holds due to missing signatures, the episode demonstrates how documentation failures can halt entire product lines. Most importantly, it reframes GDP as a cultural mindset—a proactive approach to quality rather than a bureaucratic burden. It’s a must-hear for anyone looking to understand the DNA of device quality systems.

    14 min
See All Season 25 (5)

Ratings & Reviews

4.2
out of 5
5 Ratings

About

Welcome to a Complete Drug Development Journey! Have you ever wondered how groundbreaking medicines go from a scientist’s vision to life-saving treatments in hospitals and pharmacies worldwide? The journey of drug development is an intricate, high-stakes adventure—filled with scientific breakthroughs, regulatory twists, and the relentless pursuit of innovation. In this podcast, we take you behind the scenes of pharmaceutical research and development, unraveling the complex and fascinating process that transforms a promising compound into a fully approved, market-ready medicine. Each episode is a deep dive into the critical stages of drug development, including: 🔬 Drug Discovery: Where innovation begins—exploring cutting-edge research, target identification, and the quest for the next medical breakthrough. 🧪 Preclinical Testing: Investigating safety, efficacy, and mechanisms of action before a drug ever reaches human trials. 👩‍⚕️ Clinical Trials: The rigorous, high-stakes world of human testing—what works, what fails, and what it takes to get to the finish line. 📜 Regulatory Approval: Understanding the intricate web of global regulatory agencies, FDA submissions, and the make-or-break moments for new drugs. 🏭 Manufacturing & Scale-Up: From lab to large-scale production—how pharmaceutical companies tackle formulation, stability, and distribution challenges. 💰 Market Access & Commercialization: The economics of drug development—pricing, market dynamics, and the delicate balance between innovation and accessibility. Whether you're a scientist, industry professional, investor, or simply fascinated by the inner workings of the pharmaceutical world, this podcast brings you expert insights, real-world case studies, and in-depth discussions on the past, present, and future of drug development. Join us as we demystify the science, strategy, and business behind the medicines that change lives. Subscribe now and be part of the journey! Access the Notion Template for cGXP Training Modules here: https://www.notion.so/marketplace/templates/cgxp-guidance-and-training-module ***Information in this podcast series is for education only and not meant to construe medical advice. For that, please consult your health care professional.***

Information

You Might Also Like